Meta-analysis finds Laryngeal EMG moderately predicts vocal cord paralysis recovery in children
Photo by Patrick Fore / Unsplash
Key Takeaway
Consider LEMG as a moderate predictor of VCP recovery in children, but interpret with caution due to wide confidence intervals.
This systematic review and meta-analysis evaluated the prognostic utility of Laryngeal Electromyography (LEMG) in predicting recovery from vocal cord paralysis (VCP) in pediatric patients. The qualitative analysis included 33 studies (day 1 of life to 18 years), while the meta-analysis included 5 studies (day 1 to 14 years). The primary outcome was the prognostic utility of LEMG in predicting VCP recovery.
Key findings from the meta-analysis showed a pooled sensitivity of 82% (95% CI: 51-96%) and a pooled positive predictive value of 75.0% (95% CI: 27.0% to 96.0%) for LEMG in predicting recovery. The presence of motor unit action potentials (MUAPs) was associated with a higher likelihood of recovery (hazard ratio 5.56, 95% CI: 1.65-18.71, p = 0.00558), and Kaplan-Meier curves showed significantly higher recovery rates over time in patients with MUAPs (p = 0.00094).
Limitations include wide confidence intervals for pooled estimates, a limited number of studies in the meta-analysis, and the observational nature of included studies, which precludes causal inference. The authors did not report specific limitations, but the certainty of evidence is moderate at best.
Clinically, LEMG may offer moderate accuracy in predicting favorable recovery when normal MUAPs are present, but the wide confidence intervals and small sample size suggest cautious interpretation. Further validation in larger, prospective studies is needed before routine clinical use can be recommended.
View Original Abstract ↓
OBJECTIVES: To provide a comprehensive evaluation of state-of-art Laryngeal Electromyography (LEMG) in pediatric population and quantitatively assess its prognostic utility in vocal cord paralysis (VCP).
METHODS: The systematic review and meta-analysis were carried out and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A comprehensive literature search was performed across PubMed, Scopus, and Google Scholar. Eligible studies included case reports, case series, and observational studies. Data were extracted qualitatively and pooled using a random-effects model to evaluate the prognostic utility of LEMG in predicting VCP recovery.
RESULTS: A total of 33 studies were included in the qualitative analysis, and five studies for meta-analysis. The mean age of patients in studies included for qualitative analysis was 6.77 ± 5.73 years, with an age range from day 1 of life to 18 years. In contrast, the studies included in the meta-analysis enrolled children ranging from day 1 of life to 14 years, with a mean age of 2.01 ± 1.03 years. A random-effects meta-analysis of sensitivity of three studies yielded a pooled sensitivity of 82% (95% CI: 51-96%). A meta-analysis of Positive Predictive Value (PPV) of two studies, showed a pooled PPV of 75.0% (95% CI: 27.0% to 96.0%). Cox Proportional Hazards regression analysis showed that patients with Motor Unit Action Potential (MUAP) present had 5.56 times higher likelihood of recovery than those without MUAP (Hazard Ratio = 5.56, 95% CI: 1.65-18.71, p = 0.00558). The Kaplan Meier (KM) curve analysis demonstrated patients with MUAP exhibited higher chances of recovery over time compared to those without MUAP (p = 0.00094).
CONCLUSION: LEMG in pediatric laryngology serves a valuable diagnostic, therapeutic, and prognostic adjunct with diverse applications. It shows moderate accuracy in predicting favorable recovery in cases of VCP when normal MUAPs are present.
Standardized formal resuscitation training likely reduces neonatal mortality in low- and middle-income countries compared to no training or basic training
A Simple Training Program Is Saving Newborn Lives in Poor Countries
Related in Pediatrics
Respiratory microbiome composition in children offers new ideas for precision treatment of respiratory diseases and asthma
New ideas for treating children with asthma and respiratory infections
This narrative review examines the respiratory microbiome, metabolites, and colonization in children with respiratory infections, allergic a…
This review offers fresh directions for understanding how the respiratory microbiome affects children with asthma and allergic airway inflam…
Ultrasound may aid pediatric constipation diagnosis in various clinical settings
Ultrasound scans may help doctors diagnose constipation in children
This narrative review examines the role of transabdominal and perianal ultrasonography in pediatric gastroenterology clinics and institution…
Ultrasound scans could become a useful tool for doctors treating constipation in children, offering a new way to see inside without surgery.
Case report describes bilateral simple excision in a 10-year-old child with cervical branchial remnants
Simple surgery removed rare neck growths in a 10-year-old child
This publication is a case report and review of the literature describing a 10-year-old child with bilateral cervical chondrocutaneous branc…
A 10-year-old child with rare neck growths had them removed with simple surgery, showing no safety concerns in this single case report.
High-dose quadrivalent influenza vaccine shows non-inferior immunogenicity in Chinese children aged 6 to 35 months
High-dose flu shots show greater protection for young children in China
This randomized, double-blind study in 3,000 Chinese children aged 6 to 35 months found an investigational high-dose quadrivalent influenza …
A new study in China shows high-dose flu vaccines work as well as or better than standard shots for toddlers, offering stronger protection a…
From Other Specialties
Probiotics, synbiotics, and berberine modestly lower fasting glucose and HbA1c in type 2 diabetes
Probiotics and Berberine Modestly Lower Blood Sugar in Type 2 Diabetes
This meta-analysis of over 2,000 participants found that probiotics, synbiotics, and berberine produced significant but modest reductions in…
Probiotics, synbiotics, and berberine may help lower blood sugar and HbA1c, but the effects are modest.
High-dose ocrelizumab 1200/1800 mg shows no significant difference in disability progression versus 600 mg in MS
High-dose ocrelizumab did not further reduce disability progression in multiple sclerosis patients
This phase 3b randomized controlled trial in 860 and 753 patients with relapsing or primary progressive multiple sclerosis found that high-d…
A large trial found that higher doses of ocrelizumab did not lower the risk of disability progression compared to the standard dose in multi…
Ocrelizumab reduces disability progression risk in primary progressive multiple sclerosis versus placebo
Ocrelizumab reduces disability risk for primary progressive multiple sclerosis patients
This phase 3b trial evaluated intravenous ocrelizumab versus placebo in patients with primary progressive multiple sclerosis. The study foun…
A large trial found ocrelizumab significantly lowers the risk of disability progression in patients with primary progressive multiple sclero…
Prasinezumab showed non-significant delay in motor progression versus placebo in early-stage Parkinson's disease
Early Parkinson's drug trial shows no delay in motor progression
This phase 2b trial evaluated intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable medication. The study f…
A Phase 2b trial of prasinezumab in early Parkinson's disease failed to meet its primary endpoint of delaying motor progression compared to …